Advertisement
Screener

CENCORA, INC. (COR) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$333.54(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$333.54High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-06-09COR
Cencora, Inc.
Glen SantangeloBarclays$274.08$350.00+27.70%Overweight
2026-02-12COR
Cencora, Inc.
Glen SantangeloBarclays$365.70$425.00+16.22%Overweight
2025-12-08COR
Cencora, Inc.
Glen SantangeloBarclays$337.63$400.00+18.47%Overweight
2024-11-29COR
Cencora, Inc.
Glen SantangeloBarclays$249.69Overweight
2024-11-06COR
Cencora, Inc.
Glen SantangeloBarclays$245.38$290.00+18.18%Overweight
2024-01-31COR
Cencora, Inc.
Glen SantangeloBarclays$232.68$263.00+13.03%Overweight
2024-01-02COR
Cencora, Inc.
Glen SantangeloBarclays$208.54$242.00+16.04%Overweight

Similar stocks

Stock NameCountryMarket CapPE Ratio
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
MCKESSON CORP (MCK)United States$101.317B19.78
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B